| abstract |
It is intended to provide an agent for promoting the growth of meibomian gland epithelial cells and corneal epithelial cells, and a therapeutic agent for eye diseases such as meibomian gland dysfunction and dry eyes. A preparation containing as an active ingredient, [3-[2-[4-isopropyl-2-(4-trifluoromethyl)phenyl-5-thiazolyl]ethyl]-5-methyl-1,2-benzisoxazol-6-yl]oxyacetate, [4-[3-[2-(4-trifluoromethyl)phenyl-4-isopropyl-5-thiazolyl] propionyl]2-methylphenoxy]acetate or [4-[3-[2-(2-hydroxy-4-chlorophenyl)-5-isopropyl-4-oxazolyl]propionyl]-2-methylphenoxy]acetate or a pharmacologically acceptable salt thereof is used as the agent for promoting the growth of meibomian gland epithelial cells or corneal epithelial cells and the therapeutic agent for eye diseases such as meibomian gland dysfunction and dry eyes. |